Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06059729
Other study ID # 27231-Hafsa Noreen
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 11, 2023
Est. completion date January 1, 2024

Study information

Verified date April 2024
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study plans to find the efficacy of a digital application/software, Al-lisan that adult stutters can be used for assessment and management of their stuttering. The Software has been developed with the help of a software engineer. After the current trends employed by Speech language pathologists explored through qualitative study design, the manual which is under development process through a focused group in which assessment and treatment options of the software were finalized. The next step will include the reliability and validity of the software for assessment and management of adult stutters followed by finding the efficacy of the software. As this Application will be in Urdu language it will assist less literate and those living in peripheries to assess or provide self-treatment options to the persons who stutter. It will allow adults for self-assessment and treatment options in Urdu language.


Description:

The term stuttering refers to the dis-fluent pattern of speech. In adult stuttering it's a learned pattern of dis-fluent production that may become the part of their speech permanently. It affects 1% of the worldwide population. There are many therapeutic techniques to treat the stuttering in adults. Self-help therapy is common to use. Besides the personalized treatment of self-help therapy by adult stutters, there are many digital applications available and used by many adult stutters worldwide. Few are StammerApp, Stamurai and SMAAT. The objective of the study is to develop a digital application/software that adult stutters can be used for assessment and management of their stuttering. This study being a part of PhD project, started in March 2020 and until now, the current trends employed by Speech language pathologists have been explored through qualitative study design. The manual was developed through a focused group in which assessment and treatment options of the software were finalized. The Software has been developed with the help of a software engineer. The objective of this study is to find the effects of Al-lisan Urdu Digital Software for Self-Assessment and Treatment of Adult Stutters. For this step we are applying for the grant. As this Application will be in Urdu language it will assist less literate and those living in peripheries to assess or provide self-treatment options to the persons who stutter. It will allow adults for self-assessment and treatment options in Urdu language.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date January 1, 2024
Est. primary completion date December 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: Inclusion criteria will be Stutters who are above the age of 19 and who have not taken regular therapy from last one year Exclusion Criteria: Adults with neurogenic stuttering or any other organic cause will be excluded

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Al-Lisaan
Al-Lisaan is a digital application for the self assessment and management of adult stutters.

Locations

Country Name City State
Pakistan Hafsa Noreen Lahore Punjab
Pakistan Rex Medical Center Lahore Punjab

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stutter Severity Index Stutter's severity will be measured Pre and Post experimental study. six weeks
Secondary Stuttering Severity Index Stutter's severity will be measured Pre and Post experimental study. six weeks
See also
  Status Clinical Trial Phase
Recruiting NCT02909088 - Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). Phase 2/Phase 3
Recruiting NCT05472181 - The Effects of Brain Stimulation on Speech Fluency in Adults Who Stutter N/A
Recruiting NCT06011837 - Effects of Altered Auditory Feedback on Speech Fluency N/A
Recruiting NCT05339906 - Study of the Effect of the Auditory Stimulation on Stuttering Symptoms in Patients With a Deficit of Spectral Power in the EEG Beta Frequency Band N/A
Recruiting NCT05908123 - Exploring the Nature, Assessment and Treatment of Stuttering N/A
Completed NCT05574803 - High-definition tDCS Treatment for Cantonese-speaking Adults Who Stutter N/A
Recruiting NCT06278233 - Bihemispheric Transcranial Direct Current Stimulation* on Speech Fluency N/A
Recruiting NCT04929184 - Speech Processing in Stuttering N/A